TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010
TCL Archive FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds December 26, 2003
TCL Archive NCI to Study Review Group’s report Urging Restructure of Prevention Programm June 27, 1997
TCL Archive NIH Balks At Forming New Review Groups For NCI’s Program Grants; Guidelines Draft Ready For NCAB August 2, 1974
